Healthcare >> CEO Interviews >> October 17, 2003

Leon Moulder Jr. – Mgi Pharma Inc (mogn)

LEON O. MOULDER JR. is President and Chief Executive Officer of MGI PHARMA, INC. He joined MGI PHARMA in September 1999 as Executive Vice President, was promoted to President and Chief Operating Officer in May 2002 and to his current position as President and Chief Executive Officer in May 2003. Prior to joining MGI, he was Vice President, Business Development and Commercial Affairs and was part of the founding management team of Eligix, Inc., a privately owned biomedical company focused on developing therapies for cancer, organ transplantation and autoimmune diseases. This followed 16 years of various sales, marketing, product and operational management, and business development positions with Hoechst Marion Roussel (HMR) and its predecessor companies, Marion Laboratories and Marion Merrell Dow Pharmaceuticals. Mr. Moulder's tenure at HMR culminated as Product Group Director, Oncology and Anti- Infectives. He began his career in 1980 at Temple University Hospital as a clinical pharmacist, responsible for all clinical and operational pharmacy services provided to the medical research unit and intensive care units. Mr. Moulder received a Bachelor's degree in Pharmacy from Temple University and a Master's degree in Business Administration from the University of Chicago. Profile
TWST: Would you give us a brief overview of MGI Pharma?

Mr. Moulder: MGI PHARMA, INC., is an oncology-focused biopharmaceutical

company that acquires, develops and commercializes proprietary